Cargando…

Careful use of clonazepam and alpha lipoid acid in burning mouth syndrome treatment

Detalles Bibliográficos
Autores principales:	Suga, Takayuki, Tu, Trang T. H., Nagamine, Takahiko, Toyofuku, Akira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291469/ https://www.ncbi.nlm.nih.gov/pubmed/33440037 http://dx.doi.org/10.1111/odi.13776

Ejemplares similares

Therapeutic Dose of Amitriptyline for Older Patients with Burning Mouth Syndrome
por: Suga, Takayuki, et al.
Publicado: (2019)

A case of vestibular schwannoma with oral burning sensation: surgical complication or burning mouth syndrome?
por: Suga, Takayuki, et al.
Publicado: (2021)

Real-world Discontinuation of Antidepressant Treatment in Patients with Burning Mouth Syndrome: A Chart Review
por: Watanabe, Motoko, et al.
Publicado: (2019)

Two-hit theory by estrogen in burning mouth syndrome
por: Nagamine, Takahiko
Publicado: (2022)

A case of vestibular schwannoma mimicking burning mouth syndrome
por: Suga, Takayuki, et al.
Publicado: (2021)

Personality Traits in Burning Mouth Syndrome Patients With and Without a History of Depression
por: Tu, Trang Thi Huyen, et al.
Publicado: (2021)

Comparison of Clonazepam and Tongue Protector in the Treatment of Burning Mouth Syndrome
por: Zborowski, Jacek, et al.
Publicado: (2022)

Current management strategies for the pain of elderly patients with burning mouth syndrome: a critical review
por: Tu, Trang T. H., et al.
Publicado: (2019)

Low-Dose Aripiprazole Augmentation in Amitriptyline-Resistant Burning Mouth Syndrome: Results from Two Cases
por: Takenoshita, Miho, et al.
Publicado: (2017)

Response to Treatment with Melatonin and Clonazepam versus Placebo in Patients with Burning Mouth Syndrome
por: Castillo-Felipe, Candela, et al.
Publicado: (2022)

Therapeutic effects of clonazepam in patients with burning mouth syndrome and various symptoms or psychological conditions
por: Shin, Hyun-Il, et al.
Publicado: (2023)

Low-dose aripiprazole for refractory burning mouth syndrome
por: Umezaki, Yojiro, et al.
Publicado: (2016)

Psychiatric comorbidities in chronic orofacial pain during COVID-19 pandemic
por: Maeda, Chizuko, et al.
Publicado: (2023)

Treatment of Tardive Dyskinesia by tetrabenazine, clonazepam and vitamin E
por: Sharma, Himanshu
Publicado: (2009)

Management of burning mouth syndrome
por: Shanbhag, Vagish Kumar Laxman
Publicado: (2016)

Clonazepam in Catatonia: Thinking Beyond the Boundary of Lorazepam: A Case Report
por: Agrawal, Adesh Kumar, et al.
Publicado: (2022)

Drug-induced burning mouth syndrome: a new clinico-pathological entity?
por: Fortuna, Giulio, et al.
Publicado: (2012)

“Burning mouth syndrome in Parkinson’s disease: dopamine as cure or cause?” Letter to the Editor Reply
por: Coon, Elizabeth A., et al.
Publicado: (2012)

Lipoid proteinosis: Histopathological characterization of early papulovesicular lesions
por: Gutte, Rameshwar, et al.
Publicado: (2012)

Duloxetine-induced Hyponatremia Can Occur in Not Only Syndrome of Inappropriate Secretion of Antidiuretic Hormone but Also Cerebral Salt Wasting Syndrome
por: Nagamine, Takahiko
Publicado: (2021)

Small samples, big problems: lipoid pneumonia mimicking lung adenocarcinoma
por: da Costa, Felipe Marques, et al.
Publicado: (2023)

Alpha lipoic acid efficacy in burning mouth syndrome. A controlled clinical trial
por: Palacios-Sánchez, Begoña, et al.
Publicado: (2015)

The Effectiveness and Adverse Events of Amitriptyline and Aripiprazole in Very Elderly Patients With BMS
por: Watanabe, Motoko, et al.
Publicado: (2022)

Pancytopenia associated with clonazepam
por: Bautista-Quach, Marnelli A, et al.
Publicado: (2010)

Burning Mouth Syndrome
por: Mock, David, et al.
Publicado: (2010)

Burning mouth syndrome
por: Jimson, Sudha, et al.
Publicado: (2015)

Burning Mouth Syndrome
por: Kamala, KA, et al.
Publicado: (2016)

Psychiatric diagnoses in patients with burning mouth syndrome and atypical odontalgia referred from psychiatric to dental facilities
por: Takenoshita, Miho, et al.
Publicado: (2010)

Is primary prevention of Clostridioides difficile infection possible with combination probiotics in elderly orthopedic patients?
por: NAGAMINE, Takahiko
Publicado: (2019)

Beware of bihemispheric stroke after Omicron variant infection in the elderly
por: Nagamine, Takahiko
Publicado: (2023)

Somatization and Medicalization in Patients with Unexplained Orofacial Pain
por: Nagamine, Takahiko
Publicado: (2023)

Lipoid proteinosis: a first report of mutation Val10Gly in the signal peptide of the ECM1 gene
por: Ludew, Dominik, et al.
Publicado: (2018)

Burning Mouth Syndrome and Menopause
por: Dahiya, Parveen, et al.
Publicado: (2013)

Burning mouth syndrome: etiology
por: Cerchiari, Dafne Patrícia, et al.
Publicado: (2015)

Neuroleptic malignant syndrome associated with COVID-19 vaccination
por: Nagamine, Takahiko
Publicado: (2021)

The effect of probiotics on bowel movement and metabolic parameters in schizophrenia patients: a retrospective chart review
por: NAGAMINE, Takahiko, et al.
Publicado: (2020)

Mild Decrease in Blood Glucose Levels May Predict Efficacy of Antipsychotic Lurasidone
por: Nagamine, Takahiko, et al.
Publicado: (2023)

Is MOUTHS better than MOUTH?
por: Shetti, Akshaya N
Publicado: (2013)

Burning Fog: Cognitive Impairment in Burning Mouth Syndrome
por: Canfora, Federica, et al.
Publicado: (2021)

Foreign accent syndrome associated with left insula infarction after COVID-19 pneumonia
por: Nagamine, Takahiko
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fc6ppeejfnop962e141frlfj1h